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EmbryogenesisIn mammals, the small Arf GTPase-activating protein (SMAP) subfamily of Arf GTPase-activating
proteins consists of closely related members, SMAP1 and SMAP2. These factors reportedly exert dis-
tinct functions in membrane trafficking, as manifested by different phenotypes seen in single
knockout mice. The present study investigated whether SMAP proteins interact genetically. We
report for the first time that simultaneous loss of SMAP1 and SMAP2 promotes apoptosis in the distal
region of E7.5 mouse embryos, likely resulting in embryonic lethality. Thus, at least one SMAP gene,
either SMAP1 or SMAP2, is required for proper embryogenesis.
 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
During embryogenesis, intracellular membrane traffic is
thought to be critical for signaling governing cell remodeling, cell
polarity, epithelia formation, cell fate and differentiation, all activ-
ities required for proper development [1–4]. Thus defining how
intracellular membrane traffic is regulated is essential for under-
standing embryogenesis.
GTP-binding proteins of the Arf/Sar family are key regulators of
such trafficking [5–9]. These proteins are primarily controlled by
two classes of factors: guanine nucleotide exchange factors
(GEFs) and GTPase activating proteins (GAPs). Arf GAPs are in factcritical for terminating Arf function, as Arf family proteins do not
exhibit detectable intrinsic GTPase activity.
Multiple Arf GAPs regulate activity of a single Arf. For example,
ACAP1, ACAP2, ARAP2, Git1, Git2 and SMAP1 reportedly regulate
Arf6, while ArfGAP1, ArfGAP3, ASAP1, and SMAP2 regulate Arf1
[10,11]. How multiple Arf GAPs regulate a single Arf and whether
their functions overlap or differ are currently unknown. For exam-
ple, Arf6 protein has at least two sites of opposing function defined
by the distinct Arf6 GAPs, ACAP1 and ARAP2 [12]. Genetic or func-
tional interactions among Arf GAPs remain unclear.
Among Arf GAPs, the small Arf GTPase-activating protein
(SMAP) subfamily consists of the structurally related SMAP1 and
SMAP2 proteins [13,14]. Both reportedly exert distinct functions
in membrane trafficking [13–18]. For example, SMAP1 and
SMAP2 have substrate preferences for Arf6 and Arf1, respectively.
SMAP1 functions in Arf6-dependent endocytosis of the transferrin
receptor and E-cadherin, whereas SMAP2 is involved in Arf1-
dependent membrane trafficking between early endosomes and
the trans-Golgi network (TGN). In addition, we recently showed
that mice deficient in either SMAP1 or SMAP2 exhibit different
defects, although they both develop normally [19,20]. SMAP1
Fig. 1. SMAP2 interacts physically with SMAP1. (A) SMAP2C (aa163–428) interacts with SMAP1C (aa129–440) but not with SMAP2C (aa163–428) in two independent yeast-
two hybrid assays. (B) A series of SMAP1 deletion mutants (pGADT7-SMAP1 (aa129–440), pGADT7-SMAP1 (aa129–386), pGADT7-SMAP1 (aa129–367), pGADT7-SMAP1
(aa129–349), and pGADT7-SMAP1 (aa129–242)) were examined for interaction with SMAP2 (aa163–428). + and  indicate interaction or no-interaction, respectively.
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impaired sorting of endocytosed c-kit [19], while SMAP2 deficiency
causes male infertility due to abnormal acrosome formation [20].
Thus, it is clear that some trafficking pathways depend solely on
either SMAP1 or SMAP2.
We previously identified SMAP2 and SMAP1 sequences impor-
tant for subcellular localization and specificity and showed that
the SMAP2 Arf GAP domain can function similarly to SMAP1 when
SMAP2 localization is altered artificially [17]. We also recently
found enhanced rather impaired transferrin incorporation into
SMAP1-deficient MEFs [19]. On the other hand, siRNA-mediated
SMAP2 depletion in SMAP1-deficient cells reduced transferrin
incorporation [19]; however, transferrin incorporation was not
impaired in MEFs deficient in SMAP2 only (in this report). These
findings suggest that at least one SMAP, either SMAP1 or SMAP2,
is required for transferrin incorporation in these cells.
Collectively, these observations suggest that SMAP1 and SMAP2
functionally interact, although those activities remain
uncharacterized.
In this study, we investigated potential genetic and functional
interactions of SMAP1 and SMAP2. We found that SMAP2 interacts
with SMAP1 in a yeast-two hybrid assay and that misexpressed
SMAP1 and SMAP2 co-localize in Cos7 cells and are
co-immunoprecipitated in HeLa cells. Also, for the first time, we
report genetic interaction between SMAP1 and SMAP2: loss of both
genes promoted apoptosis in the distal region of E7.5 embryos and
SMAP1/SMAP2 doubly-deficient mice showed embryonic lethality.
Thus, at least one SMAP gene, SMAP1 or SMAP2, is indispensable
for proper embryonic development.2. Materials and methods
2.1. Animals
This study was approved by the Committee of Animal
Experiments, Nara Women’s University (approval ID: 11-11).
SMAP1f/, SMAP1/ and SMAP2+/ mice were generated as previ-
ously reported [19,20].
2.2. Library transformation and screening
Library transformation and screening was done as described
[14] using the MATCHMAKER Two-Hybrid System 3 (Clontech,
Palo Alto, CA). Briefly, a pGBKT7-SMAP2 (aa163–428) plasmid
was introduced into AH109 yeast cells, and transformants were
selected on SD/-Trp plates. The resulting AH109/pGBKT7-SMAP2
strain was then transformed with a plasmid DNA library (mouse
brain; Clontech). Colonies were picked and streaked on SD/-Trp,
-Leu, -His, -Ade, +2.5 mM 3AT/X-b-Gal (20 lg/ml) plates. Select
Ade+/His+/Mel+(X-b-Gal+) colonies were further analyzed.
2.3. Plasmids
SMAP1 deletion mutants used here were as follows:
pGADT7-SMAP1 (aa129–440), pGADT7-SMAP1 (aa129–386),
pGADT7-SMAP1 (aa129–367), pGADT7-SMAP1 (aa129–349), and
pGADT7-SMAP1 (aa129–242). Each DNA fragment was inserted
into the EcoRI/XhoI sites of the pGADT7. Myc- or hemagglutinin
(HA)-tagged SMAP1 or SMAP2 expression vectors included the
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(aa1–428), pcDNA3-HA-SMAP1 (aa1–440) and pcDNA3-Myc-
SMAP2 (aa1–428). Fragments encoding full-length or partial
proteins were inserted into the EcoRI/XhoI sites of pcDNA3.
2.4. Cell culture
COS7, HeLa, and mouse embryonic fibroblast (MEF) cells were
propagated in Dulbecco’s modified Eagle medium (DMEM) con-
taining 10% (v/v) fetal bovine serum (FBS), 100 U/ml penicillin,A 
B 
C
 
HA-SMAP1 
Myc-SMAP2 
IP: an-HA 
Lysate 
+ 
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Fig. 2. Misexpressed SMAP1 and SMAP2 co-localize in Cos7 cells. (A) Cos7 cells were tra
constructs and proteins were detected by anti-HA or anti-Myc antibodies. (B) Cos7 cell
constructs and proteins detected as above. Transfected Cos7 cells stained on coverslips w
HeLa cells were transfected with indicated expression vectors. In the upper two rows, p
(WB) with indicated antibodies. In the lower two rows, protein lysates were assayed byand 100 lg/ml streptomycin. PLAT-E cells were propagated in
DMEM containing 10% FBS, 100 U/ml penicillin, 100 lg/ml strepto-
mycin, 1 lg/ml blasticidin, and 1 lg/ml puromycin. Cells were
maintained in 5% CO2 air at 37 C.
2.5. Establishment of SMAP1f/SMAP2/ mouse embryonic fibroblast
(MEF) lines
Primary MEFs were generated from mated SMAP1f/SMAP2+/
mice 14.5 days after conception according to standard methodsWB: Myc 
WB: HA 
WB: Myc 
WB: HA 
- 
+ + 
+ 
nsfected separately or simultaneously with HA-SMAP1 and Myc-SMAP2 expression
s were transfected separately or simultaneously with HA-SMAP1 and Myc-SMAP2
ere analyzed using a BX50 fluorescence microscope (Olympus). Scale bar, 20 lm. (C)
rotein lysates were immunoprecipitated with anti-HA followed by immunoblotting
immunoblotting with indicated antibodies without immunoprecipitation.
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plasmid containing SV40 genomic DNA (Large T antigen) [22].
MEFs were cultured in DMEM supplemented with 10% FBS and
antibiotics (penicillin/streptomycin) at 37 C and 5% CO2.
2.6. DNA transfection and retrovirus infection
Cos7 cells on coverslips were transfected with plasmid DNA
using Effectene (QIAGEN) according to the manufacturer’s instruc-
tions and incubated 24 h at 37 C. The procedure to prepare retro-
virus stock was as follows: PLAT-E cells seeded in a 6 cm diameter
dish (5 ml medium) without blasticidin and puromycin were trea-
ted with 200 ll serum-free DMEM containing 3 lg of pMX-Cre-
Puro and 20 ll of Fugene HD. After 24 h, the medium was changed,
and 24 h after that, virus-containing supernatant was collected.
MEFs in a 3.5 cm diameter dish were infected with 750 ll retro-
virus solution containing 8 lg/ml polybrene (Sigma). After 5 h,
medium was replaced with new medium containing 2 lg/ml
puromycin.
2.7. Establishment of SMAP1/SMAP2/ MEF lines expressing c-kit
Establishment of MEF lines expressing c-kit was done by same
methods as described [19,23]. MEFs were plated onto 3.5 cm
dishes coated with fibronectin fragments (RetroNectin, TAKARA
Bio, Shiga, Japan) and cultured with 1 ml virus supernatant for
72 h. Retrovirus-infected MEFs were isolated as GFP-positive cells
by FACS Aria (BD Biosciences, San Jose, CA).
2.8. Genotyping of mice by PCR
Genomic DNA from mouse tails or embryos was isolated by
standard methods. Genotyping was performed using PCR with
standard Taq polymerase (Greiner Bio One) or LA-Taq polymerase
(TAKARA) using primers to amplify mutant or wild-type alleles.
PCR primers were as follows: H5: 50-GTCATCCTGGTTAGCCT-
CAGTCTTG-30 and H3: 50-CCTCTGCTAACTCTACTCAGGTA-30 for the
SMAP1 wild-type allele, HS-2: 50-CCTGCCCTTACCCAGACT-
GTCTTAG-30 and H3: 50-CCTCTGCTAACTCTACTCAGGTA-30 for the
SMAP1-deleted allele, H5: 50-GTCATCCTGGTTAGCCTCAGTCTTG-30
and Frt-Rev-SM1: 50-AAGTTCCTATACTTTCTAGAGAATA-30 for the1   2    3   4   5    6   7   8
A 
C 
-/- -/- +/+
SMAP2 WT
SMAP2 KO
Fig. 3. SMAP1/SMAP2 doubly-deficient mice die embryonically. (A) E10.5 SMAP1/SMAP2 do
embryos without the yolk sac are shown. Scale bar, 500 lm. (B) E8.5 SMAP1/SMAP2 doub
genotyping of E8.5 embryos for SMAP2. Nine embryos (lanes 1–9) were analyzed for
embryos. Arrows indicate expected bands for either wild-type (upper) or SMAP2-deficieSMAP1 flox’d allele, SM2-1: 50-CACTCGGGGTCAAGTGTGCG-30 and
SM2-30: 50-CCAGAACCCCCTCCCCACTC-30 for the SMAP2 wild-type
allele, and neo13: 50-CGCCTTCTATCGCCTTCTTGACG-30 and neo21:
50-CTTTCCGCCTCAGAAGCCATAGAG-30 for the SMAP2-deleted
allele.
2.9. Immunofluorescence and immunoblot assays
Cos7 or MEF cells on coverslips were fixed with 4% (wt/vol)
formaldehyde in phosphate-buffered saline (PBS) for 15 min at
room temperature (RT) and washed with PBS. Embryos were sim-
ilarly fixed and washed. Cells and embryos were blocked with 1%
(wt/vol) bovine serum albumin and 0.1% Triton X-100 in PBS for
15 min at RT. Fixed cells and embryos were incubated with appro-
priately diluted primary (1:200) and then secondary (1:200) anti-
bodies for 60 min each in 0.05% Tween-20 in PBS at RT.
Preparation of cell lysates and co-immunoprecipitation and
immunoblot analysis were performed as described [19,24].
Signals were detected by enhanced chemiluminescence using an
LAS-4000 mini Fluoro image analyzer (Fujifilm, Tokyo, Japan).
Primary antibodies were anti-HA rat monoclonal antibody
(mAb) (3F10, Roche), anti-Myc mouse mAb (9E10, Sigma),
anti-SMAP1 rabbit polyclonal antibody (HPA030574, Sigma), and
anti-SMAP2 rabbit polyclonal antibody (HPA021466, Sigma).
Secondary antibodies were Alexa 488-conjugated anti-rat IgG,
Cy3-conjugated goat anti-rat Ig (Chemicon), Alexa 488-
conjugated anti-mouse IgG (Invitrogen), Alexa 568-conjugated
anti-mouse IgG (Invitrogen), and goat anti-rabbit IgG (H + L)
Alexa Fluor 488 (Molecular Probe) as the secondary antibody.
After washing with PBS, coverslips or embryos were mounted on
slide glasses using Prolong Gold with DAPI (Molecular Probe) and
analyzed with a confocal microscope (C1siReady, NIKON). In the
case of transfected Cos cells, coverslips were mounted in
VECTASHIELD mounting medium and observed using a BX50 fluo-
rescence microscope (Olympus, Tokyo, Japan).
2.10. Internalization assays
Monitoring of transferrin endocytosis was performed as
described [22]. Briefly, MEFs were rinsed with PBS and pre-
incubated in serum-free DMEM for 2 h at 37 C. After removal of   9
B 
+/+-/- 
ubly-deficient (/) embryos with the yolk sac and similarly staged wild-type (+/+)
ly-deficient (/) and wild-type (+/+) embryos with the yolk sac are shown. (C) PCR
WT or KO SMAP2 alleles; lanes 1 and 2 represent SMAP1/SMAP2 doubly-deficient
nt (lower) samples.
2758 M. Sumiyoshi et al. / FEBS Letters 589 (2015) 2754–2762media, MEFs were incubated with pre-warmed, serum-free DMEM
containing 100 lg/ml Alexa488-conjugated human transferrin for
15 min at 37 C [22]. After incubation, MEFs were processed for
immunofluorescence as described [22], and analyzed with a confo-
cal microscope (C1siReady, NIKON).
Monitoring of c-kit endocytosis and intracellular transport was
performed as described [19,23]. Briefly, MEFs engineered to
express c-kit were cultured on coverslips with recombinant mur-
ine SCF (PEPROTECH) at 37 C for 30 min to allow internalization.
Coverslips were mounted on slide glasses using Prolong Gold with
DAPI (Molecular Probe), and samples were analyzed with a confo-
cal microscope (C1siReady, NIKON).
To quantitate transferrin and c-kit internalization in MEFs, the
fluorescence intensity of an entire cell was measured in randomlyA B 
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Fig. 4. Transferrin endocytosis and sorting of endocytosed c-kit is comparable in SMAP1
PCR. Lanes 1 and 2 are clonal SMAP1f/-SMAP2/ and SMAP1/SMAP2/ MEF cells, resp
floxed, SMAP2-deficient, and SMAP2 wild-type alleles. (B) Immunofluorescent staining confi
SMAP1/SMAP2/ MEFs were stained with anti-SMAP1 and SMAP2 antibodies as well as
SMAP2 KO (SMAP1+/SMAP2/), and SMAP1/2 dKO (SMAP1/SMAP2/) MEFs were assa
were stained with DAPI. Scale bar, 30 lm. (D) Quantification of transferrin uptake was p
n = 64 for SMAP1 KO, n = 52 for SMAP2 KO, and n = 53 for SMAP1/2 dKO cells). ***, P, 0
+SMAP2+/+), SMAP1 KO (SMAP1/SMAP2+/+) and SMAP1/2 dKO (SMAP1/SMAP2/) MEFs
of c-kit uptake was performed as described in Section 2 (data represent means ± S.D.; n =
0.001 vs. control. Fluorescence is reported as arbitrary units (a.u.).selected individual cells (total cell area) was measured and pro-
cessed using Image J software (http://rsbweb.nih.gov/ij/index.
html).
2.11. Apoptosis detection
Apoptosis was evaluated using an Apop Tag In Situ Apoptosis
Fluorescein Detection Kit (Millipore). Briefly, E7.5 embryos were
fixed in 4% PFA/PBS at 4 C overnight and then immersed in etha-
nol: acetic acid (2:1) solution at 20 C for 20 min. Embryos were
then processed as described in the manufacturer’s protocol. Finally,
embryos were washed PBS and mounted in Prolong Gold antifade
reagent with DAPI (Invitrogen) and analyzed with a confocal
microscope (C1siReady, NIKON).SMAP2KO SMAP1/2dKO 
/SMAP2+/+ and SMAP1/SMAP2/ MEFs. (A) Established MEFs were genotyped by
ectively. Indicated PCR primers can differentiate between SMAP1-deficient, SMAP1
rming establishment of SMAP1/SMAP2/ MEFs. Wild type, SMAP1f/SMAP2/ and
DAPI. Scale bar, 10 lm. (C) WT (SMAP1+/+SMAP2+/+), SMAP1 KO (SMAP1/SMAP2+/+),
yed for transferrin endocytosis, and transferrin uptake was observed at 15 min. Cells
erformed as described in Section 2 (data represent means ± S.D.; n = 45 for WT cells,
.001 vs. control. Fluorescence is reported as arbitrary units (a.u.). (E) WT (SMAP1+/
were assayed for c-kit internalization at 30 min. Scale bar, 15 lm. (F) Quantification
42 for WT cells, n = 45 for SMAP1 KO cells and n = 51 for SMAP1/2 dKO cells). ***, P,
SMAP1KO 
SMAP1/2dKO 
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Fig. 4 (continued)
Table 1
Genotypes of offspring of crossed SMAP1/SMAP2+/ mice.
Stage SMAP1/SMAP2+/+ SMAP1/SMAP2+/ SMAP1/SMAP2/
P21 19 35 0
E10.5** 3 12 4*
E8.5 4 9 2*
E7.5 6 19 10
The total number of embryos or postnatal mice is indicated.
* Abnormal embryos.
** One empty uterus was observed.
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3.1. SMAP2 interacts with SMAP1
Using the SMAP2 C-terminal region (SMAP2C) as bait, we previ-
ously identified CALM (Clathrin Assembly Lymphoid Myeloid leu-
kemia) as a SMAP2-interacting protein [14]. To further
investigate SMAP2 function, we undertook a new yeast-two hybrid
assay using the same bait to identify additional interacting part-
ners. Unexpectedly, we identified a C-terminal SMAP1 fragment
as a SMAP2-interacting protein, although SMAP2 did not interact
with itself (Fig. 1A). Using SMAP1 C-terminal deletion mutants
(Fig. 1B), we next asked which SMAP1 region was needed for
SMAP2 interaction and identified SMAP1 aa368–aa386 (Fig. 1B).
This region reportedly contains a motif governing subcellular local-
ization [17]. Overall, these data indicate that SMAP2 and SMAP1
interact in yeast cells.
3.2. Misexpressed SMAP1 and SMAP2 co-localize in Cos7 cells
To determine whether SMAP2 and SMAP1 interact in mam-
malian cells, we transfected Cos7 cells with tagged SMAP1 and
SMAP2 expression constructs and observed protein localization
by immunofluorescence (Fig. 2). When transfected separately,
Myc-SMAP1 was distributed evenly throughout the cytoplasm,
while HA-SMAP2 showed a punctate cytoplasmic expression
pattern, as reported previously (Fig. 2A) [13,14]. When we
co-transfected Cos7 cells with Myc-SMAP1 and HA-SMAP2 con-
structs, we observed HA-SMAP2 and Myc-SMAP1 co-localization,
with Myc-SMAP1 showing a sub-cellular pattern similar to
HA-SMAP2 (Fig. 2A). To avoid potential effects of protein tags, we
undertook the same experiments with tags reversed (HA-SMAP1
and Myc-SMAP2) and obtained comparable results (Fig. 2B).
Thus, this analysis indicates that SMAP1 and SMAP2 occupy similar
subcellular sites and suggests that they interact functionally and
physically in Cos7 cells. Given that both yeast two-hybrid and
co-localization analyses suggest SMAP1/SMAP2 interaction, we
confirmed this finding by immunoprecipitation of lysates of HeLa
cells transfected with HA-SMAP1 and Myc-SMAP2. As seen in
Fig. 2C, following immunoprecipitation of HA-SMAP1 with anti-HA antibody, we detected Myc-SMAP2 in precipitates by
immunoblotting.
3.3. SMAP1 and SMAP2 doubly-deficient mice die embryonically
Next, to determine whether SMAP1 and SMAP2 genetically
interact, we crossed SMAP1/SMAP2+/ mice and genotyped sur-
viving offspring after the weaning period. Of 54 mice examined,
35 were SMAP1/SMAP2+/ and 19 were SMAP1/SMAP2+/+.
Surprisingly, we identified no viable SMAP1/SMAP2/ pups, sug-
gesting that loss of both SMAP1 and SMAP2 is lethal prior to wean-
ing (Table 1).
3.4. SMAP1 and SMAP2 doubly-deficient mice abort after E8.5
To identify the precise timing of lethality, we collected embryos
at E8.5 and the E10.5 and observed their gross appearance. We
found that embryos appeared degenerated at both stages
(Fig. 3A and B). Embryos at E10.5 were then collected and geno-
typed by PCR (Table 1). All abnormal-appearing embryos (4 of
20; 20%) were SMAP1/SMAP2/. We also observed one mouse
with an empty uterus (1 of 20; 5%). When we collected and geno-
typed E8.5 embryos by PCR (Table 1 and Fig. 3C), we found that all
abnormal-appearing embryos (2 of 15; 13%) were SMAP1/
SMAP2/. We then collected all E7.5 embryos and genotyped
them by PCR (Table 1). Of 35 embryos analyzed, 10 (28.6%) were
SMAP1/SMAP2/. These results indicate that either SMAP1 or
SMAP2 is necessary for proper embryonic development at or
around E8.5.
SMAP1+/+SMAP2+/+
SMAP1+/+SMAP2+/+
SMAP1-/-SMAP2+/+
SMAP1-/-SMAP2-/-
DAPI DAPI
A 
SMAP2
Staining
SMAP2
Staining
DAPI DAPISMAP1 Staining
SMAP1 
Staining
  
SMAP1-/-SMAP2+/- 
SMAP1-/-SMAP2-/- 
DAPI B TUNEL MERGED 
Fig. 5. SMAP1/SMAP2 loss enhances apoptosis at E7.5. (A) Immunofluorescent staining of E7.5 embryos with anti-SMAP1 and SMAP2 antibodies. (B) Results of DAPI (left
panels), TUNEL staining (middle panels) and MERGED images (right panels) are shown. E7.5 SMAP1/SMAP2+/ and SMAP1/SMAP2/ embryos are shown. Scale bar,
100 lm.
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SMAP1/SMAP2/ mice die embryonically, hindering analysis
of underlying defects. To overcome this hurdle, we established
SMAP1/SMAP2/ MEFs. Previously, we observed loss of transfer-
rin endocytosis in SMAP2 knockdown/SMAP1-deficient MEFs [19].
Thus we asked whether impaired clathrin-dependent endocytosis,
including that of transferrin, might promote SMAP1/SMAP2/
embryonic lethality. We could not establish SMAP1/SMAP2/
MEF cells directly from homozygous E8.5 and E9.5 mutant
embryos; therefore we chose to first establish immortalized
SMAP1flox/SMAP2/ MEFs by transfection with a plasmid express-
ing SV40 Large T antigen [22]. Cells were then infected by retro-
viruses harboring cre recombinase to create double homozygous
mutants. We then established SMAP1/SMAP2/ lines from single
colonies, as confirmed by PCR genotyping and immunostaining
with SMAP antibodies (Fig. 4A and B). SMAP1/SMAP2/ cells,
however, showed growth rates comparable to wild-type MEFs,suggesting that SMAP1/SMAP2 does not alter proliferation of
immortalized MEFs. When we performed transferrin up-take
experiments on SMAP1+/+SMAP2+/+, SMAP1/SMAP2+/+, SMAP1+/
SMAP2/, and SMAP1/SMAP2/ MEFs, we observed no impair-
ment but instead transferrin incorporation in SMAP1/SMAP2+/+
mice was comparable to that seen in double homozygotes (Fig. 4
C and D). We had also previously reported that SMAP1 deficiency
impaired sorting of endocytosed c-kit in MEFs. [19]. To assess
potential effects of SMAP1/SMAP2 loss on sorting of endocytosed
c-kit in MEFs, we undertook c-kit incorporation experiments in
SMAP1/SMAP2/ MEFs (Fig. 4E and F) and observed effects com-
parable to those observed in SMAP1/SMAP2+/+ MEFs.
3.6. SMAP1/SMAP2 loss promotes apoptosis at E7.5
To search for causes of abnormal embryogenesis, we first
assessed SMAP1 and SMAP2 protein expression in wild-type
embryos by immunohistochemistry. As shown in Fig. 5A
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tously in E7.5 embryos. As shown in Fig. 5B, whole mount prepara-
tions showing DAPI staining of the egg cylinder of E7.5 SMAP1/
SMAP2/ mutants revealed relative disorganization of embryonic
structures, particularly in the distal region. To determine whether
apoptosis was enhanced in abnormal embryos, we conducted
TUNEL assays of whole-mount embryos and observed an increase
in the number of TUNEL-positive cells in these distal regions of
SMAP1/SMAP2/ embryos (n = 3) (Fig. 5B), while SMAP1/
SMAP2+/ embryos were TUNEL-negative (n = 7). We conclude
that loss of SMAP 1 and 2 promotes apoptosis in distal embryonic
regions as early as E7.5, possibly resulting in lethality.
4. Discussion
Our analysis indicates that SMAP1 and SMAP2 interact geneti-
cally and complement each other during embryogenesis around
E7.5. Our data indicate that SMAP1/SMAP2/ blastocysts form,
the uterus undergoes decidualization, and embryos implant and
develop into egg cylinders. Loss of both genes promotes apoptosis
in distal embryonic tissues at E7.5, a potential cause of embryonic
lethality. In early mouse gastrulation, morphogenetic movements,
cell proliferation, and differentiation convert the embryonic por-
tion of the egg cylinder, the epiblast, into ectoderm, mesoderm,
and endoderm. Since SMAP1 and SMAP2 proteins are expressed
ubiquitously at E7.5, it is not clear whether observed
abnormalities, including apoptosis, emerge from signaling defects
in extra-embryonic ectoderm or from cell autonomous epiblast
defects.
Transferrin endocytosis and sorting of endocytosed c-kit
were also indistinguishable in SMAP1/SMAP2/ and
SMAP1/SMAP2+/+ MEFs. This data suggests that SMAP1 and
SMAP2 may have uncharacterized common targets different from
previously identified transferrin receptors, and that those novel
targets are critical for embryogenesis around E7.5. Our data also
suggests that SMAP2 plays little or no role in embryonic trans-
ferrin incorporation or sorting of endocytosed c-kit. Membrane
trafficking activity is high in embryogenesis; thus it is important
to understand function of Arfs and the factors that regulate
them, namely, Arf GAPs and GEFs [3]. Our study is significant
as it is the first report that Arf GAPs are indispensable for embry-
onic development.
ADP-ribosylation factor-related protein 1 (ARFRP1)-deficient
embryos show phenotypes similar to those of SMAP1//
SMAP2/ embryos [25]: ARFRP1 loss promotes embryonic
lethality at gastrulation stages (E6.5 to 7.5) and blocks ectoderm
differentiation. Histological analysis of ARFRP1-deficient embryos
revealed significant defects before and during gastrulation.
Pyknotic epiblast cells in the area of the primitive streak region
(at E6.5 to E7.5) were TUNEL-positive and therefore apoptotic.
The similar phenotypes exhibited by ARFRP1-deficient and
SMAP1/SMAP2/ embryos are intriguing. Since the ARFRP1
Arf GAP remains unknown, these observations suggest that
SMAP1 and SMAP2 might serve as ARFRP1 GAPs.
During preparation of this manuscript, Kobayashi et al. reported
that loss of SMAP1 togetherwith SMAP2 impairs transferrin incorpo-
ration using a non-clonal mixed MEF cell culture [26]. As noted, we
performed similar assays using stable, clonal SMAP1/SMAP2/
MEF lines and did not observe this effect. Kobayashi et al. used
immortalized SMAP1f/fSMAP2/MEFs, while we used immortalized
SMAP1f/SMAP2/ MEF recipients for retrovirus infection. At pre-
sent, we have no explanation for discrepancies in these findings.
In any case, transferrin receptor-1 and -2-deficient embryos survive
to E12.5 and are born, respectively [27,28]; thus, lack of transferrin
endocytosis cannot account for embryonic lethality triggeredaround E7.5–8.5 in SMAP1/SMAP2/ embryos. We propose that
other defects underlie these phenotypes.
In summary, we identified a novel genetic interaction between
Arf GAPs encoded by SMAP1 and SMAP2. Similar genetic interac-
tions may occur among other Arf GAPs or Arfs. Since SMAP1 and
SMAP2 are suggested to be an Arf6 GAP and Arf1 GAP, respectively,
it will be interesting to analyze a potential genetic interaction of
Arf1 and Arf6 in future studies.
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